Literature DB >> 23237768

Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma.

Ernst Lengyel1, Saroj Fleming, Kelsey A McEwen, Anthony Montag, Sarah M Temkin.   

Abstract

OBJECTIVE: Serial sectioning of the fallopian tube in women undergoing risk reducing surgery has been shown to increase the detection rate of occult malignancy in BRCA mutation carriers. We undertook this study to determine whether this protocol at the time of surgery for ovarian cancer (OV) or primary peritoneal malignancies (PP) changes the detection rate of fallopian tube carcinoma (FT). We secondarily investigated where this difference affects patient outcomes.
METHODS: A retrospective review of 130 patients treated at the University of Chicago Medical Center for ovarian, peritoneal or fallopian tube carcinoma was conducted. Sixty five patients diagnosed with OV, PP or FT who had serial sectioning of the fallopian tubes at the time of diagnoses (SS) were compared to 65 patients whose fallopian tubes were sectioned in a standard fashion (PSS).
RESULTS: Serial sectioning of the fallopian tube at the time of pathologic examination in women with presumed OV or PP led to an increase in the number of women diagnosed with FT as the primary site of origin (p<0.001). Clinical or pathologic risk factors leading to an increased risk of FT were not identified. Survival between the two groups was similar.
CONCLUSION: In women with presumed OV or PP, serial sectioning identifies women with FT. FT may be more common than previously noted; however distinct biologic or clinical behavior to differentiate it from OV or PP could not be identified. Clinical management of FT should continue to be the same as that of OV or PP.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23237768      PMCID: PMC3717384          DOI: 10.1016/j.ygyno.2012.12.006

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  22 in total

1.  Pathologic findings in prophylactic oophorectomy specimens in high-risk women.

Authors:  Katherine Leeper; Rochelle Garcia; Elizabeth Swisher; Barbara Goff; Benjamin Greer; Pamela Paley
Journal:  Gynecol Oncol       Date:  2002-10       Impact factor: 5.482

2.  Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.

Authors:  J M Piek; P J van Diest; R P Zweemer; J W Jansen; R J Poort-Keesom; F H Menko; J J Gille; A P Jongsma; G Pals; P Kenemans; R H Verheijen
Journal:  J Pathol       Date:  2001-11       Impact factor: 7.996

Review 3.  Early de novo ovarian cancer and cancer developing in benign ovarian lesions.

Authors:  R E Scully
Journal:  Int J Gynaecol Obstet       Date:  1995-07       Impact factor: 3.561

Review 4.  Origins and molecular pathology of ovarian cancer.

Authors:  Debra A Bell
Journal:  Mod Pathol       Date:  2005-02       Impact factor: 7.842

5.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

6.  Incidence of malignant fallopian tube tumors.

Authors:  K A Rosenblatt; N S Weiss; S M Schwartz
Journal:  Gynecol Oncol       Date:  1989-11       Impact factor: 5.482

7.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Authors:  Timothy R Rebbeck; Henry T Lynch; Susan L Neuhausen; Steven A Narod; Laura Van't Veer; Judy E Garber; Gareth Evans; Claudine Isaacs; Mary B Daly; Ellen Matloff; Olufunmilayo I Olopade; Barbara L Weber
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

8.  Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.

Authors:  C Bethan Powell; Eric Kenley; Lee-May Chen; Beth Crawford; Jane McLennan; Charles Zaloudek; Miriam Komaromy; Mary Beattie; John Ziegler
Journal:  J Clin Oncol       Date:  2005-01-01       Impact factor: 44.544

Review 9.  Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches.

Authors:  N Auersperg; T Ota; G W E Mitchell
Journal:  Int J Gynecol Cancer       Date:  2002 Nov-Dec       Impact factor: 3.437

10.  Early de novo ovarian carcinoma. A study of fourteen cases.

Authors:  D A Bell; R E Scully
Journal:  Cancer       Date:  1994-04-01       Impact factor: 6.860

View more
  4 in total

Review 1.  Ovarian Cancer Prevention in High-risk Women.

Authors:  Sarah M Temkin; Jennifer Bergstrom; Goli Samimi; Lori Minasian
Journal:  Clin Obstet Gynecol       Date:  2017-12       Impact factor: 2.190

Review 2.  Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.

Authors:  George U Eleje; Ahizechukwu C Eke; Ifeanyichukwu U Ezebialu; Joseph I Ikechebelu; Emmanuel O Ugwu; Onyinye O Okonkwo
Journal:  Cochrane Database Syst Rev       Date:  2018-08-24

3.  Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma.

Authors:  Hilal Gurler; Virgilia Macias; Andre A Kajdacsy-Balla; Maria V Barbolina
Journal:  Biomolecules       Date:  2015-12-03

4.  Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status.

Authors:  F Coscia; K M Watters; M Curtis; M A Eckert; C Y Chiang; S Tyanova; A Montag; R R Lastra; E Lengyel; M Mann
Journal:  Nat Commun       Date:  2016-08-26       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.